Home / Inspections / 1310476

FDA Inspection 1310476 — Central Pennsylvania Blood Bank

Central Pennsylvania Blood Bank — FEI 1000161167

The FDA completed an inspection of Central Pennsylvania Blood Bank on March 11, 2026 in Ephrata, PA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
March 11, 2026
Fiscal Year
2026
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Ephrata, PA (United States)

Facility

Other inspections at this facility

  • 1197535 (NAI Thu Feb 02 2023 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1072439 (NAI Tue Oct 30 2018 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 905793 (NAI Thu Dec 04 2014 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 817498 (NAI Thu Feb 07 2013 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 726494 (NAI Thu May 26 2011 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources